Go to the list of all blogs
Jimmy Landsman's Avatar
published in Blogs
Aug 16, 2026
TickeronGET DAILY SIGNALS
VanEck Uranium and Nuclear ETF (NLR) Rallies +13.3% in 30 Days Amid Nuclear Developments

VanEck Uranium and Nuclear ETF (NLR) Rallies +13.3% in 30 Days Amid Nuclear Developments

Key Takeaways

  • NLR rose approximately 13.3% over the 30 days through mid-August 2026, from roughly $104.20 to $118.10 per share.
  • The advance is a sharp rebound within a longer correction; the fund remains about 8.9% lower over the trailing three months.
  • Catalysts included China's approval of eight new reactors, renewed physical uranium buying by the Sprott Physical Uranium Trust, and a U.S.–Saudi nuclear cooperation announcement.
  • Miners, utilities, and reactor-technology names all participated, with the utility sleeve cushioning volatility.
  • NLR's concentrated structure—roughly half uranium-related energy exposure and about 30% utilities—drives its sentiment-sensitive swings.

VanEck Uranium and Nuclear ETF (NLR) Overview and Portfolio Exposure

The VanEck Uranium and Nuclear ETF is a passively managed, non-diversified exchange-traded fund (ETF) that seeks to replicate, before fees and expenses, the price and yield performance of the MVIS Global Uranium & Nuclear Energy Index. The index covers uranium mining, nuclear power generation, nuclear facility construction and engineering, and related equipment and services. The fund normally invests at least 80% of total assets in index securities and carries a net expense ratio of 0.52%.

NLR holds roughly 30 securities. Largest positions include Cameco (CCJ), Constellation Energy (CEG), BWX Technologies (BWXT), Public Service Enterprise Group (PEG), and PG&E (PCG), alongside uranium developers such as NexGen Energy (NXE), Denison Mines (DNN), Uranium Energy (UEC), and Centrus Energy (LEU). Energy-related uranium and fuel-cycle companies represent close to half of assets, utilities about 30%, and industrials most of the remainder. That mix shapes performance: utilities provide cash-flow ballast, while miners, enrichment names, and advanced reactor developers are more sensitive to uranium prices and risk appetite. I also checked this using Tickeron’s AI Screener to see how the stock compares to others in the industry.

NLR Price Performance: Last 30 Days vs. Quarter

From a mid-July close of $104.20, NLR advanced to $118.10 by mid-August, a gain of about 13.3%. The rally was not a steady grind: the fund bottomed near the $102–$104 area and then recovered in a series of sharp daily moves, consistent with sentiment normalization after an oversold stretch.

Over the trailing three months, the picture is different. From a mid-May close near $129.68, the fund is down roughly 8.9%, meaning the 30-day rebound has retraced only part of a larger spring pullback—a volatile, V-shaped short-term recovery set against a still-negative quarterly trend.

What Drove NLR Price in the Last 30 Days

The rebound reflected a cluster of policy and market developments. In late July, China's State Council approved four nuclear power projects totaling eight reactors, with estimated investment above 170 billion yuan, reinforcing global reactor demand. Around the same time, the Sprott Physical Uranium Trust resumed physical uranium purchases—50,000 pounds on July 21 and 100,000 pounds on each of July 29 and 30—tightening spot-market liquidity and supporting uranium-linked equities.

The U.S. administration announced a civilian nuclear cooperation arrangement with Saudi Arabia on July 22, signaling that even hydrocarbon-rich economies are adding nuclear capacity. In mid-August, TerraPower's engagement with South Korean suppliers revived investor focus on small modular reactor (SMR) orders and backlog visibility.

Commodity conditions helped as well. Uranium spot prices held near the mid-$80s per pound while long-term contract prices climbed to roughly $95 per pound, their highest in about 18 years. Among holdings, cash-generating utilities such as Constellation Energy (CEG) and Public Service Enterprise Group (PEG) steadied the portfolio, while higher-beta miners and SMR developers led the bounce.

What Drove NLR Performance Over the Last Quarter

The quarterly decline was primarily a valuation and sentiment unwind rather than a deterioration in nuclear fundamentals. NLR peaked in late January 2026, and selling accelerated from mid-May as investors questioned the pace and payoff of AI-related capital spending. Nuclear and uranium equities—heavily bid during the 2023–2025 rally—repriced as momentum faded.

Within the portfolio, the damage was uneven. Pre-revenue reactor developers such as Oklo (OKLO) and NuScale Power (SMR) fell hardest, while established power producers such as Constellation Energy (CEG) held up better. Uranium miners also weakened even as the commodity stayed firm: spot uranium remained range-bound in the mid-$80s, while long-term contract prices continued to climb. That detachment between equity prices and the underlying commodity is characteristic of a sentiment-driven de-rating.

Constructive news—including a U.S. Department of Energy conditional loan commitment of $17.5 billion for long-lead components for up to 10 large reactors and Walmart's first nuclear power purchase agreement—did not stop the selloff, but it preserved the structural demand narrative.

Analyzing Nuclear Themes with Tickeron’s AI Screener

In my research process, I often turn to Tickeron’s AI Screener to scan for securities matching specific sector criteria like uranium exposure or volatility metrics. It helps narrow the universe of names quickly using technical indicators, fundamentals, and AI-generated signals, which proved useful when reviewing NLR holdings and peers. This structured approach supports a more data-driven view of how individual components are behaving within the broader theme.

Disclaimer

The information on this webpage is provided for general informational and educational purposes only and is not intended as investment advice, a recommendation to purchase or sell any security, or an offer or solicitation related to investments. It does not consider your personal financial situation, goals, or risk profile, and all investing carries inherent risks, including the possibility of losing your entire investment. For more details, please review our full disclaimer.

Disclaimers and Limitations

Related Ticker: NLR

Contributor

My name is Jimmy, and I’m a financial analyst focused on identifying compelling opportunities across the ETF market. Each day, I analyze hundreds of ETFs to uncover potential trading and investment opportunities using a broad range of market factors. For short-term trading, I rely heavily on technical analysis, including price channels, momentum indicators, support and resistance levels, trend patterns, and other market signals. At the same time, I dedicate significant attention to evaluating ETFs from a long-term investment perspective. My objective is to build a well-balanced ETF portfolio that combines core investment holdings with more tactical and speculative positions. The goal is to create a portfolio that can participate effectively in market rallies while also remaining resilient during periods of volatility and market corrections.


NLR's RSI Oscillator ascends from oversold territory

The RSI Oscillator for NLR moved out of oversold territory on October 27, 2026. This could be a sign that the stock is shifting from a downward trend to an upward trend. Traders may want to buy the stock or call options. The A.I.dvisor looked at 29 similar instances when the indicator left oversold territory. In 28 of the 29 cases the stock moved higher. This puts the odds of a move higher at 90%.

Price Prediction Chart

Technical Analysis (Indicators)

Bullish Trend Analysis

The Moving Average Convergence Divergence (MACD) for NLR just turned positive on October 28, 2026. Looking at past instances where NLR's MACD turned positive, the stock continued to rise in 38 of 41 cases over the following month. The odds of a continued upward trend are 90%.

Following a +5.41% 3-day Advance, the price is estimated to grow further. Considering data from situations where NLR advanced for three days, in 299 of 336 cases, the price rose further within the following month. The odds of a continued upward trend are 89%.

NLR may jump back above the lower band and head toward the middle band. Traders may consider buying the stock or exploring call options.

Bearish Trend Analysis

The Stochastic Oscillator may be shifting from an upward trend to a downward trend. In 54 of 65 cases where NLR's Stochastic Oscillator exited the overbought zone, the price fell further within the following month. The odds of a continued downward trend are 83%.

The Momentum Indicator moved below the 0 level on October 29, 2026. You may want to consider selling the stock, shorting the stock, or exploring put options on NLR as a result. In 79 of 88 cases where the Momentum Indicator fell below 0, the stock fell further within the subsequent month. The odds of a continued downward trend are 90%.

Following a 3-day decline, the stock is projected to fall further. Considering past instances where NLR declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 80%.

The Aroon Indicator for NLR entered a downward trend on October 27, 2026. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.

Industry description

The investment seeks to replicate as closely as possible, before fees and expenses, the price and yield performance of the MVIS® Global Uranium & Nuclear Energy Index. The fund normally invests at least 80% of its total assets in securities that comprise the fund's benchmark index. The index includes equity securities and depositary receipts issued by companies involved in uranium and nuclear energy. The fund is non-diversified.

Market Cap

The average market capitalization across the VanEck Uranium and Nuclear ETF (NLR) ETF is 24.41B. The market cap for tickers in the group ranges from 588.53M to 91.15B. CEG holds the highest valuation in this group at 91.15B. The lowest valued company is NNE at 588.53M.

High and low price notable news

The average weekly price growth across all stocks in the VanEck Uranium and Nuclear ETF (NLR) ETF was 3%. For the same ETF, the average monthly price growth was 9%, and the average quarterly price growth was -5%. SMR experienced the highest price growth at 4%, while NNE experienced the biggest fall at -4%.

Volume

The average weekly volume growth across all stocks in the VanEck Uranium and Nuclear ETF (NLR) ETF was 6%. For the same stocks of the ETF, the average monthly volume growth was -17% and the average quarterly volume growth was 49%

Fundamental Analysis Ratings

The average fundamental analysis ratings, where 1 is best and 100 is worst, are as follows

Valuation Rating: 56
P/E Growth Rating: 51
Price Growth Rating: 72
SMR Rating: 74
Profit Risk Rating: 73
Seasonality Score: -32 (-100 ... +100)
View a ticker or compare two or three
NLR
Daily Signal:
Gain/Loss:
Interact to see
Advertisement
A.I.Advisor
published price charts
A.I. Advisor
published General Information

General Information

Category NaturalResources

Category
Natural Resources
Address
335 Madison Ave.19th FloorNew York
Phone
888-658-8287
Web
www.marketvectorsetfs.com
Interact to see
Advertisement
The Bitwise Solana Staking ETF (BSOL) advanced roughly 18% over the trailing 30 days, closely tracking a sharp rally in Solana (SOL). The move extends a broader recovery, with BSOL up approximately 77% over the past three months from its mid-2026 trough.
MSTY is an actively managed single-stock option income ETF (exchange-traded fund) that writes call options on Strategy (MSTR), formerly MicroStrategy, to generate current income. The portfolio is anchored by U.S. Treasury bills and MSTR option contracts rather than a diversified basket of equities, concentrating exposure in one volatile underlying.
AMDL has surged roughly +64% over the past 30 days, from about $47.59 to $78.10, mirroring a powerful rally in its sole underlying stock, AMD . The fund is a leveraged single-stock ETF (exchange-traded fund) designed to deliver 2x the daily return of AMD, amplifying both gains and losses.
AstraZeneca reported Q1 2026 total revenue of $15.3 billion, up 8% at constant exchange rates (CER, adjusting for currency fluctuations), beating consensus estimates around $14.8 billion. Core earnings per share (EPS) rose 5% to $2.58 at CER, amid a 12% increase in core operating profit.
Consensus estimates call for Q3 FY2026 revenue of approximately $3.37 billion, in line with the company's guidance midpoint of $3.35 billion. Non-GAAP earnings per share (EPS) expected at $9.16, edging above the guided midpoint of $9.08.